Nobel laureate, discoverer of HIV, sees 'hope' for cure

July 20, 2012 in HIV & AIDS

The Nobel laureate who helped to discover HIV says there is hope for an AIDS cure following recent discoveries, in an interview with AFP ahead of a global conference on the disease.

Francoise Barre-Sinoussi, who won the Nobel Prize in Medicine in 2008 as part of a team that discovered the human immunodeficiency virus (HIV) which causes AIDS, said scientific research had made major strides since then.

She cited a patient in Berlin who appears to have been cured through a bone marrow transplant, "which proves that finding a way of eliminating the virus from the body is something that is realistic."

Other sources of optimism are the small minority of patients -- less than 0.3 percent -- who exhibit no symptoms of the virus without ever receiving treatment; and a small group in France who received antiretroviral drugs and now live without treatment or symptoms, Barre-Sinoussi said.

"There is hope... but don't ask me for a date because we do not know."

She also said that it would be possible "in principle" to eliminate the AIDS pandemic by 2050, if barriers to drug access could be eliminated.

The main barriers there were not scientific but political, economic and social, she said: the problem was lack of access to testing and drugs in poor and rural areas, as well as the stigma around the virus, which undermines early detection and treatment.

Some 25,000 people -- including celebrities, scientists and HIV sufferers -- are expected in the US capital on Sunday to call for more strident global action to address the three-decade AIDS epidemic.

"At the Washington conference we are expecting greater mobilization... to widen access to current treatments and to continue research into HIV," Barre-Sinoussi said.

Deaths and infections are down in the parts of the world most ravaged by the disease, while the number of people on treatment has risen 20 percent from 2010 to 2011, reaching eight million people in needy countries.

However this is only about half the people who should be on treatment worldwide, suggesting much more remains to be done.

More than 34 million people worldwide are living with HIV, a higher number than ever before, and around 30 million have died from AIDS-related causes since the disease first emerged in the 1980s, according to UNAIDS.

(c) 2012 AFP

3 /5 (2 votes)  

Rank 3 /5 (2 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Integrating mental health care into HIV care

The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...

HIV & AIDS created 6 hours ago | popularity not rated yet | comments 0

After a decade, global AIDS program looks ahead

(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...

HIV & AIDS created 19 hours ago | popularity not rated yet | comments 0

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV & AIDS created May 19, 2013 | popularity 5 / 5 (1) | comments 0

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

HIV & AIDS created May 18, 2013 | popularity 5 / 5 (2) | comments 0

Peer-referral programs can increase HIV-testing in emergency departments

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.